{
    "2021-07-01": [
        [
            {
                "time": "",
                "original_text": "净利预增800倍，热景靠新冠检测又现夸张数据，“慢热型”终赶上“疫情红利”尾巴",
                "features": {
                    "keywords": [
                        "净利预增",
                        "新冠检测",
                        "疫情红利"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业月报：国内疫苗接种量高速增长 关注新冠疫苗出海机会",
                "features": {
                    "keywords": [
                        "疫苗接种",
                        "新冠疫苗",
                        "出海机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业月报：关注中报预期的投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报预期",
                        "投资机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "投资策略报告：2021年7月金股组合",
                "features": {
                    "keywords": [
                        "投资策略",
                        "金股组合"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}